Latest News
Skincare company BeautyHealth (NASDAQ:SKIN) announced better-than-expected revenue in Q1 CY2025, but sales fell by 14.5% year on year to $69.6 million. On the other hand, next quarter’s revenue guidance of $73.5 million was less impressive, coming in 2.9% below analysts’ estimates. Its GAAP loss of $0.08 per share was 37.6% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
E-commerce florist and gift retailer 1-800-FLOWERS (NASDAQ:FLWS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 12.6% year on year to $331.5 million. Its non-GAAP loss of $0.71 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 8, 2025
Trump has lowered the U.S. dollar, this has allowed China to print.
Via Talk Markets · May 8, 2025
Topgolf releases its first-quarter results and announces a new agreement with Topgolf.
Via Benzinga · May 8, 2025
U.S. dollar rally has weak bounce and Fed stands pat.
Via Talk Markets · May 8, 2025
J.P. Morgan analyst Bill Peterson maintained an Overweight rating on EVgo Inc (NASDAQ:EVGO) with a $5 price target, citing strong revenue driven by the eXtend business and reaffirmed financial guidance. The DOE loan remains on track, easing investor concerns.
Via Benzinga · May 8, 2025
Genetic testing company Natera (NASDAQ:NTRA). announced better-than-expected revenue in Q1 CY2025, with sales up 36.5% year on year to $501.8 million. The company’s full-year revenue guidance of $1.98 billion at the midpoint came in 3.1% above analysts’ estimates. Its GAAP loss of $0.50 per share was 21.4% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Mobile game developer Skillz (NYSE:SKLZ) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 11.2% year on year to $22.41 million. Its GAAP loss of $0.92 per share was 16.4% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Composite decking and railing products manufacturer Trex Company (NYSE:TREX) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 9% year on year to $340 million. Its GAAP profit of $0.56 per share was 4.1% below analysts’ consensus estimates.
Via StockStory · May 8, 2025
Via The Motley Fool · May 8, 2025
While the U.S. has a slim lead in AI, China has the edge when it comes to energy – and the U.S. will need to play catchup (and fast).
Via Talk Markets · May 8, 2025
Logistics solutions provider Hub Group (NASDAQ:HUBG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 8.4% year on year to $915.2 million. The company’s full-year revenue guidance of $3.8 billion at the midpoint came in 5.6% below analysts’ estimates. Its GAAP profit of $0.44 per share was 3% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 22.7% year on year to $177.8 million. The company expects the full year’s revenue to be around $742.5 million, close to analysts’ estimates. Its non-GAAP profit of $1.49 per share was 2.8% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s revenue guidance of $140 million was less impressive, coming in 3.6% below analysts’ estimates. Its GAAP loss of $0.28 per share was 40.6% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Via Benzinga · May 8, 2025
Via Benzinga · May 8, 2025
Via Benzinga · May 8, 2025
Via Benzinga · May 8, 2025
Bitcoin miner CleanSpark reportes first-quarter financial results after the market close on Thursday. Here's an overview of the report.
Via Benzinga · May 8, 2025
The Dollar rallied back to the top of the 100 handle. VIX is now at the level where we will start looking for a correction.
Via Talk Markets · May 8, 2025
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $604.7 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Boutique fitness studio franchisor Xponential Fitness (NYSE:XPOF) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.3% year on year to $76.88 million. The company expects the full year’s revenue to be around $320 million, close to analysts’ estimates. Its non-GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 8, 2025
Experiential tourism company Pursuit Attractions and Hospitality (NYSE:PRSU) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 86.3% year on year to $37.58 million. Its non-GAAP loss of $0.96 per share was 31.5% below analysts’ consensus estimates.
Via StockStory · May 8, 2025
HubSpot beats analyst estimates in the first quarter and raised guidance. Here are the key highlights.
Via Benzinga · May 8, 2025
Home security and automation software provider Alarm.com (NASDAQ:ALRM) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 7% year on year to $238.8 million. The company expects the full year’s revenue to be around $983.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.54 per share was 13.8% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per share was 3.2% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Smart security company Arlo (NYSE:ARLO) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 4.1% year on year to $119.1 million. Its non-GAAP profit of $0.15 per share was 28.2% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Energy drink company Monster Beverage (NASDAQ:MNST) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 2.3% year on year to $1.85 billion. Its non-GAAP profit of $0.47 per share was 2.2% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Foodservice packaging supplier Karat Packaging (NASDAQ:KRT) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 8.4% year on year to $103.6 million. Guidance for next quarter’s revenue was better than expected at $123.9 million at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $0.30 per share was 5.3% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Via Benzinga · May 8, 2025
Via The Motley Fool · May 8, 2025
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 18.9% year on year to $90.82 billion. Its non-GAAP profit of $10.12 per share was 3% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Tata Steel and Rio Tinto stand to benefit from the US-UK trade deal.
Via Talk Markets · May 8, 2025
Real estate technology company Compass (NYSE:COMP) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 28.7% year on year to $1.36 billion. Next quarter’s revenue guidance of $2.08 billion underwhelmed, coming in 1.5% below analysts’ estimates. Its non-GAAP loss of $0.09 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 8, 2025
Serve Robotics reports first-quarter revenue of $440,460, missing analyst estimates of $486,670, according to Benzinga Pro.
Via Benzinga · May 8, 2025
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 24.4% year on year to $483.6 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $455 million was less impressive, coming in 9.4% below expectations. Its non-GAAP profit of $0.06 per share was 37.7% below analysts’ consensus estimates.
Via StockStory · May 8, 2025
Secondhand luxury marketplace The RealReal (NASDAQ: REAL) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 11.3% year on year to $160 million. On the other hand, next quarter’s revenue guidance of $159 million was less impressive, coming in 0.8% below analysts’ estimates. Its non-GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.
Via StockStory · May 8, 2025
Trade war tailwinds were blowing for stocks today, with the Dow and Nasdaq both adding triple digits, the tech-heavy latter making a run at 18,000.
Via Talk Markets · May 8, 2025
Analog chipmaker Microchip Technology (NASDAQ:MCHP) announced better-than-expected revenue in Q1 CY2025, but sales fell by 26.8% year on year to $970.5 million. On top of that, next quarter’s revenue guidance ($1.05 billion at the midpoint) was surprisingly good and 5.1% above what analysts were expecting. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Via StockStory · May 8, 2025
(BPT) - By 2030, more than 20% of the U.S. population - about 71 million Americans - will be over the age of 65. With age, many of us may notice changes in cognition - things like misplacing our keys or forgetting a neighbor's name. While we expect our bodies to change with age and aren't alarmed when they do, many people assume the worst when their memory or cognition changes. It's important to understand that our brains age just like our bodies.
Via Brandpoint · May 8, 2025
Russell 2000 advanced 36.76 points or 1.85% to 2,026.42.
Via Talk Markets · May 8, 2025
Satellite communications provider Globalstar (NASDAQ:GSAT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 6.3% year on year to $60.03 million. On the other hand, the company’s full-year revenue guidance of $272.5 million at the midpoint came in 3.1% above analysts’ estimates. Its GAAP loss of $0.16 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 8, 2025
Via Benzinga · May 8, 2025
Casual salad chain Sweetgreen (NYSE:SG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 5.4% year on year to $166.3 million. On the other hand, the company’s full-year revenue guidance of $750 million at the midpoint came in 1.8% below analysts’ estimates. Its GAAP loss of $0.21 per share was in line with analysts’ consensus estimates.
Via StockStory · May 8, 2025
Restaurant software company (NYSE:OLO) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 21.3% year on year to $80.68 million. Guidance for next quarter’s revenue was better than expected at $82.25 million at the midpoint, 0.5% above analysts’ estimates. Its non-GAAP profit of $0.07 per share was in line with analysts’ consensus estimates.
Via StockStory · May 8, 2025
Expedia stock is falling Thursday after Q1 results. Management commentary on domestic travel could be the reason. Here's what they said.
Via Benzinga · May 8, 2025